№ lp_1_26999
File format: docx
Character count: 20931
File size: 2530 KB
List of resources for purchase recommended for NHS Medicines Information Services to ensure safe and efficient service delivery.
Year:
2020
Region / city:
UK
Theme:
Medicines Information
Document type:
List
Organization / institution:
NHS
Author:
UKMi
Target audience:
NHS Medicines Information Services
Period of validity:
Ongoing, updated quarterly
Approval date:
November 2020
Date of changes:
May 2020
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)
Year:
2024
Region / city:
Denmark
Topic:
Medicine, Health Economics
Document type:
Template
Organization / institution:
Danish Medicines Council
Author:
Danish Medicines Council
Target audience:
Pharmaceutical companies
Period of validity:
Ongoing
Approval date:
10 September 2024
Date of changes:
1 April 2025
Version:
2.5
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2018
Region / City:
Wellington, New Zealand
Topic:
Medicine administration
Document type:
Guideline
Organization / Institution:
New Zealand Nurses Organisation
Author:
New Zealand Nurses Organisation
Target audience:
Nurses, midwives
Period of validity:
Not specified
Approval date:
2018
Date of changes:
Not specified
ISBN:
978-1-877461-66-8
Note:
Year
Contextual description:
A regulatory submission form for post-marketing safety updates on human medicines, including details of the product, safety variations, and exposure data for Switzerland and worldwide.
Year:
2013
Region / City:
Long Beach, CA
Topic:
Maintenance and repair of medical equipment
Document Type:
Cooperative Agreement
Agency:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Contractors, healthcare system providers
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Jurisdiction:
Wisconsin, United States
Document type:
Agreement
Subject matter:
Purchase and sale of an easement
Parties:
Seller and Buyer
Buyer agency:
Wisconsin Department of Transportation, Bureau of Aeronautics
Governing law references:
Wisconsin Statutes §§ 32.09, 32.195, 32.20
Property location:
Wisconsin
Consideration:
Purchase price payable at closing
Closing date:
On or before ________, 20
Title conveyed:
Easement interest
Signatories:
Seller; Wisconsin Department of Transportation, Bureau of Aeronautics representatives
Legal effect:
Legally enforceable contract
Year:
Not specified
Region / City:
Not specified
Subject:
Purchase order quality requirements
Document Type:
Quality requirements
Organization / Institution:
Auto Metal Craft, Inc.
Author:
Not specified
Target Audience:
Suppliers
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
Quality management requirements for suppliers to Auto Metal Craft, Inc., outlining standards for product conformity, non-conforming product handling, packaging, and supplier performance monitoring.
Note:
Date of Application
Financing Amount Required:
RM
Bank Charges:
AmBank Islamic Berhad Charges Paid By Us. Please Debit Our Account No.:
Year:
2025
Region / City:
Singapore, Japan, China Mainland
Topic:
Maritime Vessel Sale and Purchase Agreement
Document Type:
Contract
Organization:
Cosco Shipping Energy Transportation Co Ltd
Author:
Not specified
Target Audience:
Buyers and Sellers in maritime transactions
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified